CT
Contineum Therapeutics, Inc. Class A Common Stock (CTNM)
NASDAQ·Healthcare·Biotechnology
$12.00
+1.18%
Mkt Cap $429.57M
Analyst Ratings
Buy
1
Hold
2
Sell
0
Price Target (9 analysts)
$17.33
Range $14.00 – $22.00
Implied Upside
+44.4%
Consensus $17.33 vs current $12.00